Comparison of long‐term use of prolonged‐release ropinirole and immediate‐release dopamine agonists in an observational study in patients with Parkinson's disease

PURPOSE: To estimate the risk of dyskinesia and impulse control disorders (ICDs) in patients with Parkinson's disease (PD) prescribed ropinirole prolonged‐release (R‐PR) compared to those prescribed immediate‐release dopamine agonists (IR‐DA) as monotherapy. METHODS: PD patients initiating R‐PR...

Descripción completa

Detalles Bibliográficos
Autores principales: Gungabissoon, Usha, Kirichek, Oksana, El Baou, Céline, Galwey, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Original Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317950/
https://www.ncbi.nlm.nih.gov/pubmed/32153056
http://dx.doi.org/10.1002/pds.4986

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7317950/
https://www.ncbi.nlm.nih.gov/pubmed/32153056
http://dx.doi.org/10.1002/pds.4986

Ejemplares similares